The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Continuous Blood Glucose Monitoring Systems Market Research Report 2025
Synopsis
A CGM system provides continuous insight into glucose levels throughout the day and night. The device displays information about glucose direction and rate of change providing users additional information to help with their diabetes management. Studies have shown that CGM systems may help reduce your A1C and reduce your risk for hypoglycemia, whether you are on insulin injections or pump Therapy.
The global Continuous Blood Glucose Monitoring Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Continuous Blood Glucose Monitoring Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Blood Glucose Monitoring Systems.
Report Scope
The Continuous Blood Glucose Monitoring Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Blood Glucose Monitoring Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Blood Glucose Monitoring Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Lifescan
Ascensia Diabetes Care
Dexcom
Medtronic
Ypsomed
B. Braun Melsungen
Nipro
Sanofi
Arkray
Prodigy Diabetes Care
Acon Laboratories
Nova Biomedical
Segment by Type
Self-Monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Segment by Application
Self/Home Care
Hospital & Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Blood Glucose Monitoring Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A CGM system provides continuous insight into glucose levels throughout the day and night. The device displays information about glucose direction and rate of change providing users additional information to help with their diabetes management. Studies have shown that CGM systems may help reduce your A1C and reduce your risk for hypoglycemia, whether you are on insulin injections or pump Therapy.
The global Continuous Blood Glucose Monitoring Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Continuous Blood Glucose Monitoring Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Blood Glucose Monitoring Systems.
Report Scope
The Continuous Blood Glucose Monitoring Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Blood Glucose Monitoring Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Blood Glucose Monitoring Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Lifescan
Ascensia Diabetes Care
Dexcom
Medtronic
Ypsomed
B. Braun Melsungen
Nipro
Sanofi
Arkray
Prodigy Diabetes Care
Acon Laboratories
Nova Biomedical
Segment by Type
Self-Monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Segment by Application
Self/Home Care
Hospital & Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Blood Glucose Monitoring Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Self-Monitoring Blood Glucose Systems
1.2.3 Continuous Glucose Monitoring Systems
1.3 Market by Application
1.3.1 Global Continuous Blood Glucose Monitoring Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Self/Home Care
1.3.3 Hospital & Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Continuous Blood Glucose Monitoring Systems Market Perspective (2019-2030)
2.2 Continuous Blood Glucose Monitoring Systems Growth Trends by Region
2.2.1 Global Continuous Blood Glucose Monitoring Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Continuous Blood Glucose Monitoring Systems Historic Market Size by Region (2019-2024)
2.2.3 Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Region (2025-2030)
2.3 Continuous Blood Glucose Monitoring Systems Market Dynamics
2.3.1 Continuous Blood Glucose Monitoring Systems Industry Trends
2.3.2 Continuous Blood Glucose Monitoring Systems Market Drivers
2.3.3 Continuous Blood Glucose Monitoring Systems Market Challenges
2.3.4 Continuous Blood Glucose Monitoring Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Continuous Blood Glucose Monitoring Systems Players by Revenue
3.1.1 Global Top Continuous Blood Glucose Monitoring Systems Players by Revenue (2019-2024)
3.1.2 Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Players (2019-2024)
3.2 Global Continuous Blood Glucose Monitoring Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Continuous Blood Glucose Monitoring Systems Revenue
3.4 Global Continuous Blood Glucose Monitoring Systems Market Concentration Ratio
3.4.1 Global Continuous Blood Glucose Monitoring Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Continuous Blood Glucose Monitoring Systems Revenue in 2023
3.5 Continuous Blood Glucose Monitoring Systems Key Players Head office and Area Served
3.6 Key Players Continuous Blood Glucose Monitoring Systems Product Solution and Service
3.7 Date of Enter into Continuous Blood Glucose Monitoring Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Continuous Blood Glucose Monitoring Systems Breakdown Data by Type
4.1 Global Continuous Blood Glucose Monitoring Systems Historic Market Size by Type (2019-2024)
4.2 Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Type (2025-2030)
5 Continuous Blood Glucose Monitoring Systems Breakdown Data by Application
5.1 Global Continuous Blood Glucose Monitoring Systems Historic Market Size by Application (2019-2024)
5.2 Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Continuous Blood Glucose Monitoring Systems Market Size (2019-2030)
6.2 North America Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2019-2024)
6.4 North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Continuous Blood Glucose Monitoring Systems Market Size (2019-2030)
7.2 Europe Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2019-2024)
7.4 Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size (2019-2030)
8.2 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Continuous Blood Glucose Monitoring Systems Market Size (2019-2030)
9.2 Latin America Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2019-2024)
9.4 Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size (2019-2030)
10.2 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Continuous Blood Glucose Monitoring Systems Introduction
11.1.4 Abbott Laboratories Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Continuous Blood Glucose Monitoring Systems Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Lifescan
11.3.1 Lifescan Company Detail
11.3.2 Lifescan Business Overview
11.3.3 Lifescan Continuous Blood Glucose Monitoring Systems Introduction
11.3.4 Lifescan Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.3.5 Lifescan Recent Development
11.4 Ascensia Diabetes Care
11.4.1 Ascensia Diabetes Care Company Detail
11.4.2 Ascensia Diabetes Care Business Overview
11.4.3 Ascensia Diabetes Care Continuous Blood Glucose Monitoring Systems Introduction
11.4.4 Ascensia Diabetes Care Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.4.5 Ascensia Diabetes Care Recent Development
11.5 Dexcom
11.5.1 Dexcom Company Detail
11.5.2 Dexcom Business Overview
11.5.3 Dexcom Continuous Blood Glucose Monitoring Systems Introduction
11.5.4 Dexcom Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.5.5 Dexcom Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Continuous Blood Glucose Monitoring Systems Introduction
11.6.4 Medtronic Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.6.5 Medtronic Recent Development
11.7 Ypsomed
11.7.1 Ypsomed Company Detail
11.7.2 Ypsomed Business Overview
11.7.3 Ypsomed Continuous Blood Glucose Monitoring Systems Introduction
11.7.4 Ypsomed Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.7.5 Ypsomed Recent Development
11.8 B. Braun Melsungen
11.8.1 B. Braun Melsungen Company Detail
11.8.2 B. Braun Melsungen Business Overview
11.8.3 B. Braun Melsungen Continuous Blood Glucose Monitoring Systems Introduction
11.8.4 B. Braun Melsungen Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.8.5 B. Braun Melsungen Recent Development
11.9 Nipro
11.9.1 Nipro Company Detail
11.9.2 Nipro Business Overview
11.9.3 Nipro Continuous Blood Glucose Monitoring Systems Introduction
11.9.4 Nipro Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.9.5 Nipro Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Continuous Blood Glucose Monitoring Systems Introduction
11.10.4 Sanofi Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.10.5 Sanofi Recent Development
11.11 Arkray
11.11.1 Arkray Company Detail
11.11.2 Arkray Business Overview
11.11.3 Arkray Continuous Blood Glucose Monitoring Systems Introduction
11.11.4 Arkray Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.11.5 Arkray Recent Development
11.12 Prodigy Diabetes Care
11.12.1 Prodigy Diabetes Care Company Detail
11.12.2 Prodigy Diabetes Care Business Overview
11.12.3 Prodigy Diabetes Care Continuous Blood Glucose Monitoring Systems Introduction
11.12.4 Prodigy Diabetes Care Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.12.5 Prodigy Diabetes Care Recent Development
11.13 Acon Laboratories
11.13.1 Acon Laboratories Company Detail
11.13.2 Acon Laboratories Business Overview
11.13.3 Acon Laboratories Continuous Blood Glucose Monitoring Systems Introduction
11.13.4 Acon Laboratories Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.13.5 Acon Laboratories Recent Development
11.14 Nova Biomedical
11.14.1 Nova Biomedical Company Detail
11.14.2 Nova Biomedical Business Overview
11.14.3 Nova Biomedical Continuous Blood Glucose Monitoring Systems Introduction
11.14.4 Nova Biomedical Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
11.14.5 Nova Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Self-Monitoring Blood Glucose Systems
Table 3. Key Players of Continuous Glucose Monitoring Systems
Table 4. Global Continuous Blood Glucose Monitoring Systems Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Continuous Blood Glucose Monitoring Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Continuous Blood Glucose Monitoring Systems Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Continuous Blood Glucose Monitoring Systems Market Share by Region (2019-2024)
Table 8. Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Continuous Blood Glucose Monitoring Systems Market Share by Region (2025-2030)
Table 10. Continuous Blood Glucose Monitoring Systems Market Trends
Table 11. Continuous Blood Glucose Monitoring Systems Market Drivers
Table 12. Continuous Blood Glucose Monitoring Systems Market Challenges
Table 13. Continuous Blood Glucose Monitoring Systems Market Restraints
Table 14. Global Continuous Blood Glucose Monitoring Systems Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Continuous Blood Glucose Monitoring Systems Market Share by Players (2019-2024)
Table 16. Global Top Continuous Blood Glucose Monitoring Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Blood Glucose Monitoring Systems as of 2023)
Table 17. Ranking of Global Top Continuous Blood Glucose Monitoring Systems Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Continuous Blood Glucose Monitoring Systems Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Continuous Blood Glucose Monitoring Systems Product Solution and Service
Table 21. Date of Enter into Continuous Blood Glucose Monitoring Systems Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Continuous Blood Glucose Monitoring Systems Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Type (2019-2024)
Table 25. Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Type (2025-2030)
Table 27. Global Continuous Blood Glucose Monitoring Systems Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Application (2019-2024)
Table 29. Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Application (2025-2030)
Table 31. North America Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Continuous Blood Glucose Monitoring Systems Product
Table 49. Abbott Laboratories Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. F. Hoffmann-La Roche Company Detail
Table 52. F. Hoffmann-La Roche Business Overview
Table 53. F. Hoffmann-La Roche Continuous Blood Glucose Monitoring Systems Product
Table 54. F. Hoffmann-La Roche Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 55. F. Hoffmann-La Roche Recent Development
Table 56. Lifescan Company Detail
Table 57. Lifescan Business Overview
Table 58. Lifescan Continuous Blood Glucose Monitoring Systems Product
Table 59. Lifescan Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 60. Lifescan Recent Development
Table 61. Ascensia Diabetes Care Company Detail
Table 62. Ascensia Diabetes Care Business Overview
Table 63. Ascensia Diabetes Care Continuous Blood Glucose Monitoring Systems Product
Table 64. Ascensia Diabetes Care Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 65. Ascensia Diabetes Care Recent Development
Table 66. Dexcom Company Detail
Table 67. Dexcom Business Overview
Table 68. Dexcom Continuous Blood Glucose Monitoring Systems Product
Table 69. Dexcom Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 70. Dexcom Recent Development
Table 71. Medtronic Company Detail
Table 72. Medtronic Business Overview
Table 73. Medtronic Continuous Blood Glucose Monitoring Systems Product
Table 74. Medtronic Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 75. Medtronic Recent Development
Table 76. Ypsomed Company Detail
Table 77. Ypsomed Business Overview
Table 78. Ypsomed Continuous Blood Glucose Monitoring Systems Product
Table 79. Ypsomed Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 80. Ypsomed Recent Development
Table 81. B. Braun Melsungen Company Detail
Table 82. B. Braun Melsungen Business Overview
Table 83. B. Braun Melsungen Continuous Blood Glucose Monitoring Systems Product
Table 84. B. Braun Melsungen Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 85. B. Braun Melsungen Recent Development
Table 86. Nipro Company Detail
Table 87. Nipro Business Overview
Table 88. Nipro Continuous Blood Glucose Monitoring Systems Product
Table 89. Nipro Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 90. Nipro Recent Development
Table 91. Sanofi Company Detail
Table 92. Sanofi Business Overview
Table 93. Sanofi Continuous Blood Glucose Monitoring Systems Product
Table 94. Sanofi Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Arkray Company Detail
Table 97. Arkray Business Overview
Table 98. Arkray Continuous Blood Glucose Monitoring Systems Product
Table 99. Arkray Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 100. Arkray Recent Development
Table 101. Prodigy Diabetes Care Company Detail
Table 102. Prodigy Diabetes Care Business Overview
Table 103. Prodigy Diabetes Care Continuous Blood Glucose Monitoring Systems Product
Table 104. Prodigy Diabetes Care Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 105. Prodigy Diabetes Care Recent Development
Table 106. Acon Laboratories Company Detail
Table 107. Acon Laboratories Business Overview
Table 108. Acon Laboratories Continuous Blood Glucose Monitoring Systems Product
Table 109. Acon Laboratories Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 110. Acon Laboratories Recent Development
Table 111. Nova Biomedical Company Detail
Table 112. Nova Biomedical Business Overview
Table 113. Nova Biomedical Continuous Blood Glucose Monitoring Systems Product
Table 114. Nova Biomedical Revenue in Continuous Blood Glucose Monitoring Systems Business (2019-2024) & (US$ Million)
Table 115. Nova Biomedical Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Continuous Blood Glucose Monitoring Systems Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Continuous Blood Glucose Monitoring Systems Market Share by Type: 2023 VS 2030
Figure 3. Self-Monitoring Blood Glucose Systems Features
Figure 4. Continuous Glucose Monitoring Systems Features
Figure 5. Global Continuous Blood Glucose Monitoring Systems Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Continuous Blood Glucose Monitoring Systems Market Share by Application: 2023 VS 2030
Figure 7. Self/Home Care Case Studies
Figure 8. Hospital & Clinics Case Studies
Figure 9. Continuous Blood Glucose Monitoring Systems Report Years Considered
Figure 10. Global Continuous Blood Glucose Monitoring Systems Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Continuous Blood Glucose Monitoring Systems Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Continuous Blood Glucose Monitoring Systems Market Share by Region: 2023 VS 2030
Figure 13. Global Continuous Blood Glucose Monitoring Systems Market Share by Players in 2023
Figure 14. Global Top Continuous Blood Glucose Monitoring Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Blood Glucose Monitoring Systems as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Continuous Blood Glucose Monitoring Systems Revenue in 2023
Figure 16. North America Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Continuous Blood Glucose Monitoring Systems Market Share by Country (2019-2030)
Figure 18. United States Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Continuous Blood Glucose Monitoring Systems Market Share by Country (2019-2030)
Figure 22. Germany Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Share by Region (2019-2030)
Figure 30. China Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Continuous Blood Glucose Monitoring Systems Market Share by Country (2019-2030)
Figure 38. Mexico Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Share by Country (2019-2030)
Figure 42. Turkey Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Abbott Laboratories Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 45. F. Hoffmann-La Roche Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 46. Lifescan Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 47. Ascensia Diabetes Care Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 48. Dexcom Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 49. Medtronic Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 50. Ypsomed Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 51. B. Braun Melsungen Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 52. Nipro Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 54. Arkray Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 55. Prodigy Diabetes Care Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 56. Acon Laboratories Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 57. Nova Biomedical Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
